Reducing medications safely to meet life’s changes
What medications were good then might not be the best choice now. Deprescribing is the planned process of reducing or stopping medications that may no longer be of benefit or may be causing harm. The goal is to reduce medication burden or harm while improving quality of life.
Be part of the change for a better quality of life
Patients
Learn about deprescribing and check out resources to help you discuss deprescribing with your health care provider.
Health Care Providers
Get comfortable deprescribing with tools and resources, case reports and testimonials, and relevant publications.
Researchers
Find out about ongoing research at Bruyère Research Institute and the University of Montreal and join the conversation to share your own research.
As the population ages, older Canadians are living with multiple chronic conditions. In 2016, 35% of community-dwelling seniors had chronic use of 5 or more different drug classes.
Inappropriate prescriptions are known to pose health risks for older adults, leading to unnecessary hospitalisations and undue cost.
“It is an art of no little importance to administer medicines properly; but it is an art of much greater and more difficult acquisition to know when to suspend or altogether omit them.”
What’s happening?
Dr. Barbara Farrell, has been awarded the 2019 CIHR Betty Havens Prize for Knowledge Translation in Aging
Congratulations to Dr. Barbara Farrell, who has been awarded the 2019 Canadian Institutes of Health Research (CIHR) Betty Havens Prize for Knowledge Translation in Aging! The Betty Havens Prize is awarded to researchers for their outstanding achievements in...
Millions of Canadians using acid-reflux drugs for too long, risking health side-effects
May 5, 2019 - Doctors are warning that millions of Canadians are taking a commonly prescribed class of drugs used to treat acid reflux much longer than the recommended two-month period, upping the risk of a number of health-related side-effects. Read more
Evaluation of a Deprescribing Guideline Mobile Application
The four evidence-based deprescribing guidelines and algorithms produced through the leadership of the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, and the guideline developed through an NHMRC-ARC Dementia Research Fellowship have been built...
Keep up with the latest
Yes - we’ve been consulting with them on this awesome initiative! twitter.com/mike5laffin/st…
The weekend is finally here, is there a better time to brush up on #deprescribing? deprescribing.org/resources/depr… tapermd.com/taper-guide/
New report discusses prescription medications and the importance of personalized care and shared decision-making to… twitter.com/i/web/status/1…
Dr. Barb Farrell presenting a 3 minute update on the #deprescribing research teams work at @bruyerecare… twitter.com/i/web/status/1…
The #deprescribing team is excited to celebrate #research and take part in #lifechangingday @bruyerecare https://t.co/ydj0VExbsl
A new drug–drug interaction (DDI) risk calculator (DDIRC) is set to be developed by @ElsevierConnect and other eval… twitter.com/i/web/status/1…
Would you like to get more involved?
Are you a patient, a caregiver or a researcher? You can participate in the deprescribing conversation. Find out more.
Would you like more information?
We are here to help you. If you wish to obtain more information concerning elements found on our site, please contact us.